Related Experiment Video
Updated: Jun 3, 2026
06:09
An In Ovo Model for Testing Insulin-mimetic Compounds
Published on: April 23, 2018
[Recent progress in study of oral insulin delivery]
1Department of Endocrinology and Metabolism, West China Hospital, Sichuan University, Chengdu 610041, China.
Summary
Researchers are developing non-injecting insulin delivery methods for diabetes treatment. Oral insulin offers an ideal, safe, and easy alternative to injections, with recent progress and future potential discussed.
Area of Science:
- Pharmaceutical Sciences
- Biotechnology
- Drug Delivery Systems
Context:
- Diabetes mellitus management requires effective insulin administration.
- Current insulin delivery methods often involve injections, posing challenges for patient adherence and comfort.
- Non-injecting insulin administration is a significant area of pharmaceutical research.
Purpose:
- To review the clinical value and recent advancements in oral insulin delivery.
- To discuss the mechanisms, therapeutic effects, and limitations of oral insulin formulations.
- To explore future perspectives in the development of oral insulin for diabetes treatment.
Summary:
- Oral insulin is a promising non-injecting alternative for diabetes management.
- This review covers recent progress, mechanisms, efficacy, and challenges of oral insulin delivery systems.
- Key aspects include clinical value, therapeutic effects, and future research directions.
Impact:
- Oral insulin delivery could revolutionize diabetes care by offering a convenient and patient-friendly alternative to injections.
- Advancements in this field may improve treatment adherence and quality of life for individuals with diabetes.
- Successful development of oral insulin holds significant potential for the pharmaceutical industry and global health outcomes.
Related Concept Videos
01:27Insulin Formulations: Types and Delivery
Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into rapid-acting...
Short-acting insulins are divided into rapid-acting...
01:23Oral Drug Delivery Systems: Introduction
Oral drug delivery is the most common route of administration due to its convenience, cost-effectiveness, and high patient compliance. It enables precise formulation to ensure proper drug dosage and bioavailability. The development of oral dosage forms considers drug properties such as solubility, stability, and absorption to optimize therapeutic efficacy.Tablets, capsules, liquids, and chewable formulations enhance drug stability, mask undesirable tastes, and improve patient experience.
01:06Oral Hypoglycemic Agents: Glinides
Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively manages...
01:26Oral Drug Delivery Systems: Continuous-Release Systems
Continuous-release drug delivery systems offer a strategic approach to maintaining therapeutic drug levels over extended periods following oral administration. By modulating the release rate of active pharmaceutical ingredients, these systems minimize fluctuations in plasma concentrations, which enhances clinical efficacy and reduces the need for frequent dosing. Such characteristics make them particularly advantageous in managing chronic diseases where patient adherence and stable drug...
01:11Oral Drug Delivery Systems: Delayed-Release Systems
Delayed-release drug delivery systems are specialized pharmaceutical formulations designed to postpone the release of active compounds until the drug reaches a specific region of the gastrointestinal (GI) tract, typically the intestine. These systems are essential for drugs that may cause gastric irritation, are unstable in acidic environments, or need to exert therapeutic effects locally in the intestinal or colonic regions.The core feature of delayed-release systems is the use of enteric...
01:25Insulin: Biosynthesis, Chemistry, and Preparation
The endoplasmic reticulum (ER) of pancreatic β-cells synthesizes preproinsulin, which consists of a signal peptide, A and B chains, and a C-peptide. Preproinsulin is then cleaved and folded into proinsulin, which translocates to the Golgi apparatus for sorting and packaging into secretory granules. In these granules, enzymatic clipping generates insulin and C-peptide.
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment primarily uses...
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment primarily uses...